
Tenatoprazole
CAS No. 113712-98-4
Tenatoprazole ( TU-199 | Tenatoprazole | Ulsacare | Protop )
产品货号. M17835 CAS No. 113712-98-4
替那拉唑是质子泵抑制剂 (PPI) 类的前药,可以抑制质子转运 (IC50: 3.2 μM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥381 | 有现货 |
![]() ![]() |
25MG | ¥510 | 有现货 |
![]() ![]() |
50MG | ¥616 | 有现货 |
![]() ![]() |
100MG | ¥867 | 有现货 |
![]() ![]() |
200MG | ¥1320 | 有现货 |
![]() ![]() |
500MG | ¥2252 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Tenatoprazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述替那拉唑是质子泵抑制剂 (PPI) 类的前药,可以抑制质子转运 (IC50: 3.2 μM)。
-
产品描述Tenatoprazole, also known as TU-199, is a proton pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ulcer. Tenatoprazole has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors, and has a half-life about seven times longer than other PPIs.
-
体外实验——
-
体内实验——
-
同义词TU-199 | Tenatoprazole | Ulsacare | Protop
-
通路Others
-
靶点Other Targets
-
受体Proton pump
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number113712-98-4
-
分子量346.4
-
分子式C16H18N4O3S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (144.34 mM)
-
SMILESCOc1ccc2[nH]c(nc2n1)S(=O)Cc1c(C)c(OC)c(C)cn1
-
化学全称5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Shin JM, et al. Biochem Pharmacol, 2006, 71(6), 837-849.
产品手册




关联产品
-
Silybin B
Silybin B is an effective inhibitor of raloxifene 4 '- and 6-glucosalylation, an effective anti-fibrinogenic and anti-oligomeric component of Silymarin, with free radical scavenging activity of 1, 1-diphenyl-2-pyridinyl hydrazine (DPPH), and a protective effect against cisplatin-induced neurotoxicity by alleviating DNA damage and apoptosis.
-
Biotin-ONP
(+)-Biotin-ONP 是一种基于烷基链的 PROTAC 连接体,可用于 PROTAC 的合成。
-
Murepavadin TFA
Murepavadin (TFA) is a 14-amino acid cyclic peptide that is a potent, specific antibiotic used to treat bacterial infections caused by Pseudomonas aeruginosa.Murepavadin (TFA) targets the LPS transporter portin D.